Amicus Therapeutics Balance Sheet (2010-2025) | FOLD

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Balance Sheet	Mar2021	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025
Assets
Current Assets
Cash & Equivalents (Quarter)	184.83M	176.54M	385.90M	245.20M	233.32M	235.64M	277.59M	148.81M	160.60M	211.31M	263.32M	246.99M	209.76M	209.34M	233.65M	213.75M	181.70M	158.70M	190.55M	214.01M
Short-term Investments (Quarter)	232.60M	206.53M	171.06M	237.30M	177.88M	151.20M	77.11M	144.78M	106.51M	54.32M	16.98M	39.21M	29.84M	50.73M	16.11M	36.19M	68.92M	72.30M	73.29M	79.53M
Cash & Current Investments (Quarter)	417.43M	383.07M	556.96M	482.50M	411.19M	386.84M	354.70M	293.60M	267.11M	265.63M	280.30M	286.20M	239.60M	260.06M	249.76M	249.95M	250.62M	231.00M	263.84M	293.54M
Receivables - Net (Quarter)	44.93M	49.17M	51.43M	52.67M	52.42M	52.56M	52.30M	66.20M	68.18M	63.72M	73.33M	87.63M	76.43M	85.17M	98.07M	101.10M	88.32M	105.85M	113.84M	115.31M
Receivables - Other (Quarter)
Receivables (Quarter)	44.93M	49.17M	51.43M	52.67M	52.42M	52.56M	52.30M	66.20M	68.18M	63.72M	73.33M	87.63M	76.43M	85.17M	98.07M	101.10M	88.32M	105.85M	113.84M	115.31M
Work In Process (Quarter)
Finished Goods (Quarter)
Inventory (Quarter)	18.80M	24.09M	22.07M	26.82M	24.32M	20.88M	13.27M	23.82M	27.00M	51.38M	56.94M	59.70M	60.76M	81.32M	115.34M	118.78M	132.41M	154.88M	177.93M	228.82M
Prepaid Assets (Quarter)	21.73M	24.18M	20.08M	34.85M	30.96M	37.37M	38.26M	40.21M	37.41M	52.10M	52.69M	49.53M	54.44M	35.15M	35.31M	34.91M	39.49M	46.28M	38.46M	38.51M
Current Assets (Quarter)	502.89M	480.50M	650.54M	596.83M	518.90M	497.64M	458.54M	423.82M	399.70M	432.82M	463.26M	483.06M	431.24M	461.70M	498.47M	504.74M	510.80M	538.01M	594.07M	676.17M
Non-Current Assets
Property, Plant & Equipment (Net) (Quarter)	43.45M	42.37M	41.99M	42.50M	34.54M	33.66M	32.45M	30.78M	31.41M	30.24M	31.07M	31.67M	32.42M	31.16M	30.44M	29.38M	28.72M	28.57M	27.76M	27.11M
Long-Term Investments (Quarter)
Goodwill (Quarter)	197.80M	197.80M	197.80M	197.80M	197.80M	197.80M	197.80M	197.80M	197.80M	197.80M	197.80M	197.80M	197.80M	197.80M	197.80M	197.80M	197.80M	197.80M	197.80M	197.80M
Intangibles (Quarter)	23.00M	23.00M	23.00M	23.00M	23.00M	23.00M	23.00M	23.00M	22.96M	22.14M	21.32M	20.49M	19.67M	18.85M	18.03M	17.20M	16.39M	15.57M	14.74M	13.90M
Goodwill & Intangibles (Quarter)	220.80M	220.80M	220.80M	220.80M	220.80M	220.80M	220.80M	220.80M	220.76M	219.94M	219.12M	218.29M	217.47M	216.65M	215.82M	215.00M	214.19M	213.37M	212.54M	211.70M
Other Non-Current Assets (Quarter)	20.54M	21.20M	22.08M	24.43M	25.19M	18.05M	17.87M	19.24M	20.17M	19.05M	21.13M	18.55M	17.66M	17.36M	18.68M	13.64M	14.00M	13.37M	12.90M	13.74M
Non-Current Assets (Quarter)	307.14M	306.39M	306.13M	308.31M	308.04M	302.95M	300.99M	300.35M	300.82M	297.27M	300.83M	294.82M	290.55M	287.78M	288.08M	280.30M	279.04M	277.30M	274.75M	273.70M
Assets (Quarter)	810.03M	786.89M	956.67M	905.14M	826.94M	800.59M	759.53M	724.17M	700.52M	730.09M	764.08M	777.88M	721.79M	749.48M	786.56M	785.03M	789.84M	815.30M	868.81M	949.87M
Liabilities
Current Liabilities
Accounts Payables (Quarter)	16.11M	13.76M	24.47M	21.51M	22.91M	23.11M	12.05M	15.41M	24.96M	13.52M	23.15M	15.12M	9.21M	32.06M	13.48M	12.95M	14.45M	13.89M	19.10M	28.63M
Notes Payables (Quarter)
Payables (Quarter)	16.11M	13.76M	24.47M	21.51M	22.91M	23.11M	12.05M	15.41M	24.96M	13.52M	23.15M	15.12M	9.21M	32.06M	13.48M	12.95M	14.45M	13.89M	19.10M	28.63M
Accumulated Expenses (Quarter)	57.18M	71.33M	72.45M	98.15M	80.38M	114.70M	125.23M	93.64M	92.75M	124.87M	138.53M	144.25M	124.62M	127.90M	136.12M	127.30M	129.88M	145.14M	171.16M	200.46M
Other Accumulated Expenses (Quarter)
Short term Debt (Quarter)	19.60M	19.80M	17.00M	18.90M	19.15M	19.27M	19.83M	21.42M	12.67M	13.01M
Current Leases (Quarter)	6.76M	7.11M	7.17M	7.41M	7.25M	7.54M	7.54M	8.55M	8.01M	7.84M	7.76M	8.32M	8.27M	8.11M	8.54M	8.46M	8.56M	8.61M	8.66M	8.74M
Current Deferred Revenue (Quarter)
Total Current Liabilities (Quarter)	99.65M	111.99M	121.10M	145.97M	129.70M	164.62M	164.65M	139.02M	138.38M	159.24M	169.45M	167.69M	142.10M	168.07M	158.14M	148.70M	152.89M	167.65M	198.93M	237.83M
Non-Current Liabilities
Non-Current Debt (Quarter)
Convertible Debt (Quarter)
Non-Current Deffered Revenue (Quarter)
Non-Current Deferred Tax Liability (Quarter)	4.90M	4.90M	4.90M	4.93M	4.93M	4.93M	4.93M	4.94M
Operating Leases (Quarter)	44.43M	44.20M	43.49M	50.77M	50.46M	52.84M	52.01M	51.58M	51.35M	50.98M	52.45M	57.20M	47.83M	47.01M	46.62M	45.08M	44.20M	43.38M	42.17M	49.70M
Other Non-Current Liabilities (Quarter)	26.30M	27.32M	6.82M	20.34M	19.15M	19.27M	0.08M	21.42M	9.00M	9.00M	15.00M	0.07M	12.77M	0.07M	0.07M	7.10M	8.49M			4.18M
Total Non-Current Liabilities (Quarter)	532.84M	545.66M	573.22M	577.43M	569.17M	607.90M	626.88M	579.70M	588.95M	609.51M	615.85M	617.63M	578.32M	616.89M	607.66M	583.89M	587.79M	611.00M	638.39M	671.45M
Total Liabilities (Quarter)	559.14M	572.98M	580.05M	597.77M	588.32M	627.16M	626.96M	601.12M	597.95M	618.51M	630.85M	617.71M	591.10M	616.96M	607.73M	590.99M	596.28M	611.00M	638.39M	675.63M
Shareholder's Equity
Total Debt (Quarter)	19.60M	19.80M	17.00M	18.90M	19.15M	19.27M	19.83M	21.42M	12.67M	13.01M
Common Equity (Quarter)	250.90M	213.91M	376.63M	307.37M	238.62M	173.43M	132.56M	123.05M	102.57M	111.58M	133.24M	160.17M	130.69M	132.52M	178.82M	194.04M	193.56M	204.30M	230.42M	274.24M
Shareholder's Equity (Quarter)	250.90M	213.91M	376.63M	307.37M	238.62M	173.43M	132.56M	123.05M	102.57M	111.58M	133.24M	160.17M	130.69M	132.52M	178.82M	194.04M	193.56M	204.30M	230.42M	274.24M
Liabilities and Shareholders Equity (Quarter)	810.03M	786.89M	956.67M	905.14M	826.94M	800.59M	759.53M	724.17M	700.52M	730.09M	764.08M	777.88M	721.79M	749.48M	786.56M	785.03M	789.84M	815.30M	868.81M	949.87M
Treasury Shares (Quarter)		7.41M		7.34M	10.35M			9.72M	9.43M	10.37M	10.33M	10.03M	9.56M	9.54M	9.45M	8.28M	0.01M	0.01M	12.15M	7.39M
Retained Earnings (Quarter)	-2100.00M	-2162.35M	-2212.64M	-2295.92M	-2400.00M	-2443.34M	-2476.62M	-2532.49M	-2585.42M	-2600.00M	-2650.23M	-2684.07M	-2700.00M	-2748.19M	-2754.92M	-2740.18M	-2800.00M	-2786.29M	-2768.98M	-2767.29M

Research Tools

Amicus Therapeutics Balance Sheet (2010-2025) | FOLD

Create an account

Sign In

Reset Password